Q2FY23 Quarterly Result Announced for Metropolis Healthcare Ltd.
Metropolis Healthcare announced Q2FY23 results: Q2FY23: Wellness revenue increased by 40% YoY to Rs. 33 crore EBITDA margin at Rs. 83 crore (Before CSR & ESOP) stood at 27.6% Specialized tests contributed 40% to the Non-Covid revenue Total Revenues grew by 12.4% YoY Specialized tests revenues grew by 15% YoY Wellness tests revenues grew by 36% YoY Patient & Tests volumes grew by 10% YoY Rs. 41 crore Profit After Tax Rs. 83 crore EBITDA Rs. 288 crore Covid Revenue Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Ltd, said: “I am extremely pleased to share that we have recorded highest ever quarterly revenue with 16% growth on year-on-year basis. With accelerated shift from the unorganised to the organised sector coupled with increased health awareness amongst customers and a trusted scientific image with medical fraternity, we expect the revenues growth to improve and margins to sustain at the precovid levels We have seen growth in our volumes & patient count and with increased investments in digital & marketing, manpower & customer experience initiatives, we are optimistic of sustaining the growth going forward. Our revenue contribution from wellness segment has increased to 12% in Q2FY23 & has witnessed a healthy growth of 40% on YoY basis; a testimony to our on-ground efforts and the acceptance of Metropolis Brand in the minds of consumers and medical fraternity." Result PDF08-11-2022